EUCTR2007-004814-15-IT进行中（未招募）不适用
Radiochemotherapy in association with capecitabine and oxaliplatin in the treatment of pancreatic and biliary tract, unresectable cancer: a dose escalation study - XelOx -P07
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2007年10月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Histologically proved carcinoma of pancreas or biliary tract
- •measurable disease
- •age >18 years
- •performance status (ECOG) 0-1
- •no previous chemio or radiotherapeutic treatments
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •previous radiotherapy or chemiotherapy
- •renal failure
- •hepatic failure
研究者
相似试验
已完成
1 期
Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist Anakinra for rectal cancer patients. A phase I trial of the German Rectal Cancer Study GroupC20Malignant neoplasm of rectumDRKS00025477niversitätsklinikum Frankfurt Goethe-Universität Frankfurt am Main12
进行中（未招募）
不适用
eoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced, K-ras mutated rectal cancer. A randomized multicenter phase I/II trial.Advanced K-ras mutated rectal cancer.EUCTR2008-006312-38-HUSAKK (Swiss Group for Clinical Cancer Research)47
进行中（未招募）
不适用
eoadjuvant radiotherapy and capecitabine with or without panitumumab in patients with advanced, K-ras unmutated rectal cancer. A randomized multicenter phase II trial.EUCTR2008-006012-38-HUSAKK (Swiss Group for Clinical Cancer Research)67
进行中（未招募）
1 期
Combination of radiotherapy and chemotherapy for patients with oligometastatic colorectal cancer.EUCTR2011-005296-16-DEniversity Medical Center Hamburg-Eppendorf72
进行中（未招募）
不适用
Preoperative Radiotherapy with Capecitabine and Bevacizumab in locally advanced rectal cancer: CRAB Phase II study - CRABEUCTR2008-002902-20-SIOnkološki inštitut Ljubljana